Recomendaciones para no especialistas | 11 NOV 19

Enfermedad ulcerosa péptica

La úlcera péptica se presenta con síntomas dispépticos y puede ser difícil de distinguir clínicamente. Puede tener complicaciones potencialmente graves, como sangrado. o perforación, con un elevado riesgo de mortalidad
Autor/a: Emma Sverdén, Lars Agréus, Jason M Dunn, Jesper Lagergren Peptic ulcer disease. BMJ 2019;367:l5495.ç
INDICE:  1. Página 1 | 2. Referencias bibliográficas
Referencias bibliográficas

1 Sung JJ, Kuipers EJ, El-Serag HB. Systematic review: the global incidence and prevalence of peptic ulcer disease. Aliment Pharmacol Ther 2009;29:938-46.10.1111/j.1365-2036.2009.03960.x 19220208

2 Heidelbaugh JJ, Goldberg KL, Inadomi JM. Magnitude and economic effect of overuse of antisecretory therapy in the ambulatory care setting. Am J Manag Care 2010;16:e228-34.21250399

3 Pasina L, Nobili A, Tettamanti M, etal. REPOSI Investigators. Prevalence and appropriateness of drug prescriptions for peptic ulcer and gastro-esophageal reflux disease in a cohort of hospitalized elderly. Eur J Intern Med 2011;22:205-10.10.1016/j.ejim.2010.11.009 21402255

4 Lanas A, Boers M, Nuevo J. Gastrointestinal events in at-risk patients starting non-steroidal anti-inflammatory drugs (NSAIDs) for rheumatic diseases: the EVIDENCE study of European routine practice. Ann Rheum Dis 2015;74:675-81.10.1136/annrheumdis-2013-204155 24351518

5 van den Bemt PM, Chaaouit N, van Lieshout EM, Verhofstad MH. Noncompliance with guidelines on proton pump inhibitor prescription as gastroprotection in hospitalized surgical patients who are prescribed NSAIDs. Eur J Gastroenterol Hepatol 2016;28:857-62. 10.1097/MEG.0000000000000634 27046006

6 Kim JJ, Lee JS, Olafsson S, Laine L. Low adherence to Helicobacter pylori testing in hospitalized patients with bleeding peptic ulcer disease. Helicobacter 2014;19:98-104.10.1111/hel.12114 24617668

7 Murakami TT, Scranton RA, Brown HE, etal . Management of Helicobacter Pylori in the United States: Results from a national survey of gastroenterology physicians. Prev Med 2017;100:216-22. 10.1016/j.ypmed.2017.04.021 28457713

9 Boltin D, Kimchi N, Dickman R, Gingold- Belfer R, Niv Y, Birkenfeld S. Attitudes and practice related to Helicobacter pylori infection among primary care physicians. Eur J Gastroenterol Hepatol 2016;28:1035-40. 10.1097/MEG.0000000000000659 27167452

10 Werdmuller BF, van der Putten AB, Loffeld RJ. The clinical presentation of peptic ulcer disease. Neth J Med 1997;50:115-9. 10.1016/S0300-2977(96)00075-7 9121595

11 Cai S, García Rodríguez LA, Massó-González EL, Hernández-Díaz S. Uncomplicated peptic ulcer in the UK: trends from 1997 to 2005. Aliment Pharmacol Ther 2009;30:1039-48. 10.1111/j.1365-2036.2009.04131.x 19709097

12 Aro P, Storskrubb T, Ronkainen J, etal . Peptic ulcer disease in a general adult population: the Kalixanda study: a random population-based study. Am J Epidemiol 2006;163:1025-34.10.1093/aje/kwj129 16554343

13 Agréus L, Hellström PM, Talley NJ, etal . Towards a healthy stomach? Helicobacter pylori prevalence has dramatically decreased over 23 years in adults in a Swedish community. United European Gastroenterol J 2016;4:686-96. 10.1177/2050640615623369 27733911

14 Leow AH, Lim YY, Liew WC, Goh KL. Time trends in upper gastrointestinal diseases and Helicobacter pylori infection in a multiracial Asian population—a 20-year experience over three time periods. Aliment Pharmacol Ther 2016;43:831-7. 10.1111/apt.13550 26847417

15 Marshall BJ, McGechie DB, Rogers PA, Glancy RJ. Pyloric Campylobacter infection and gastroduodenal disease. Med J Aust 1985;142:439-44.3982346

16 Graham DY, Klein PD, Opekun AR, Boutton TW. Effect of age on the frequency of active Campylobacter pylori infection diagnosed by the [13C]urea breath test in normal subjects and patients with peptic ulcer disease. J Infect Dis 1988;157:777-80.10.1093/infdis/157.4.777 3346569

17 Hansson LE, Nyrén O, Hsing AW, etal . The risk of stomach cancer in patients with gastric or duodenal ulcer disease. N Engl J Med 1996;335:242-9.10.1056/NEJM199607253350404 8657240

18 Ford AC, Forman D, Hunt RH, Yuan Y, Moayyedi P. Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and meta-analysis of randomised controlled trials. BMJ 2014;348:g3174.10.1136/bmj.g3174 24846275

19 Gisbert JP, Calvet X. Review article: Helicobacter pylori-negative duodenal ulcer disease. Aliment Pharmacol Ther 2009;30:791-815. 10.1111/j.1365-2036.2009.04105.x 19706147

20 Konturek J, Bielanski W, Plonka M, etal . Helicobacter pylori, non-steroidal anti-inflammatory drugs and smoking in risk pattern of gastroduodenal ulcers. Scand J Gastroenterol 2003;38:923-30. 10.1080/00365520310004696 14531527

21 Allison MC, Howatson AG, Torrance CJ, Lee FD, Russell RI. Gastrointestinal damage associated with the use of nonsteroidal antiinflammatory drugs. N Engl J Med 1992;327:749-54. 10.1056/NEJM199209103271101 1501650

22 Yeomans ND, Lanas AI, Talley NJ, etal . Prevalence and incidence of gastroduodenal ulcers during treatment with vascular protective doses of aspirin. Aliment Pharmacol Ther 2005;22:795-801. 10.1111/j.1365-2036.2005.02649.x 16225488

23 Rafaniello C, Ferrajolo C, Sullo MG, etal . Risk of gastrointestinal complications associated to NSAIDs, low-dose aspirin and their combinations: Results of a pharmacovigilance reporting system. Pharmacol Res 2016;104:108-14. 10.1016/j.phrs.2015.12.026 26739516

24 Zhou Y, Boudreau DM, Freedman AN. Trends in the use of aspirin and nonsteroidal anti-inflammatory drugs in the general U.S. population. Pharmacoepidemiol Drug Saf 2014;23:43-50. 10.1002/pds.3463 23723142

25 Silverstein FE, Faich G, Goldstein JL, etal . Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study. JAMA 2000;284:1247-55. 10.1001/jama.284.10.1247 10979111

26 Coblijn UK, Goucham AB, Lagarde SM, Kuiken SD, van Wagensveld BA. Development of ulcer disease after Roux-en-Y gastric bypass, incidence, risk factors, and patient presentation: a systematic review. Obes Surg 2014;24:299-309.

10.1007/s11695-013-1118-5 24234733

27 El-Hayek K, Timratana P, Shimizu H, Chand B. Marginal ulcer after Roux-en-Y gastric bypass: what have we really learned?Surg Endosc 2012;26:2789-96.10.1007/s00464-012-2280-x 22543994

28 Kurata JH, Nogawa AN. Meta-analysis of risk factors for peptic ulcer. Nonsteroidal antiinflammatory drugs, Helicobacter pylori, and smoking. J Clin Gastroenterol 1997;24:2-17. 10.1097/00004836-199701000-00002 9013343

29 Dall M, Schaffalitzky de Muckadell OB, Lassen AT, Hallas J. There is an association between selective serotonin reuptake inhibitor use and uncomplicated peptic ulcers: a population-based case-control study. Aliment Pharmacol Ther 2010;32:1383-91.10.1111/j.1365-2036.2010.04472.x 21050241

30 Jiang HY, Chen HZ, Hu XJ, etal . Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal bleeding: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 2015;13:42-50.e3. 10.1016/j.cgh.2014.06.021 24993365

31 Krag M, Perner A, Wetterslev J, etal. SUP-ICU co-authors. Prevalence and outcome of gastrointestinal bleeding and use of acid suppressants in acutely ill adult intensive care patients. Intensive Care Med 2015;41:833-45. 10.1007/s00134-015-3725-1 25860444

32 Tamura J, Arakaki S, Shibata D, Maeshiro T. Cytomegalovirus-associated gastric ulcer: a diagnostic challenge in a patient of fulminant hepatitis with steroid pulse therapy. BMJ Case Rep 2013;2013. 10.1136/bcr-2013-010501 23997079

33 Levenstein S, Rosenstock S, Jacobsen RK, et al. Psychological stress increases risk for peptic ulcer, regardless of Helicobacter pylori infection or use of nonsteroidal anti-inflammatory drugs. Clin Gastroenterol Hepatol 2015;13:498-506 e1.

34 Friedman GD, Siegelaub AB, Seltzer CC. Cigarettes, alcohol, coffee and peptic ulcer. N Engl J Med 1974;290:469-73. 10.1056/NEJM197402282900901 4810814

35 Shimamoto T, Yamamichi N, Kodashima S, etal . No association of coffee consumption with gastric ulcer, duodenal ulcer, reflux esophagitis, and non-erosive reflux disease: a cross-sectional study of 8,013 healthy subjects in Japan. PLoS One 2013;8:e65996.10.1371/journal.pone.0065996 23776588

36 Chung CS, Chiang TH, Lee YC. A systematic approach for the diagnosis and treatment of idiopathic peptic ulcers. Korean J Intern Med 2015;30:559-70.10.3904/kjim.2015.30.5.559 26354049

37 Charpignon C, Lesgourgues B, Pariente A, etal. Group de l’Observatoire National des Ulcères de l’Association Nationale des HépatoGastroentérologues des Hôpitaux Généraux (ANGH). Peptic ulcer disease: one in five is related to neither Helicobacter pylori nor aspirin/NSAID intake. Aliment Pharmacol Ther 2013;38:946-54.10.1111/apt.12465 23981105

38 Freston JW. Review article: role of proton pump inhibitors in non-H. pylori-related ulcers. Aliment Pharmacol Ther 2001;15(Suppl 2):2-5.10.1046/j.1365-2036.2001.00114.x 11556873

39 National Institute for Health and Care Excellence. The management of dyspepsia in adult patients in primary care, guidelines from National Institute for Health and Clinical Excellence. London: NICE, 2004.

40 Gralnek IM, Dumonceau JM, Kuipers EJ, etal . Diagnosis and management of nonvariceal upper gastrointestinal hemorrhage: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 2015;47:a1-46. 10.1055/s-0034-1393172 26417980

41 National Institute for Health and Care Excellence. Suspected cancer: recognition and referral. Guidelines from National Institute for Health and Clinical Excellence. NICE guidelines 2015.



Para ver los comentarios de sus colegas o para expresar su opinión debe ingresar con su cuenta de IntraMed.

Términos y condiciones de uso | Todos los derechos reservados | Copyright 1997-2022